eMedicine Specialties > Pulmonology > Acid-Base Disorders

Respiratory Acidosis

Author: Wael El Minaoui, MBBS, Fellow in Pulmonary/Critical Care Medicine, East Tennessee State University
Coauthor(s): Ryland P Byrd Jr, MD, Professor, Department of Internal Medicine, Division of Pulmonary Medicine and Critical Care Medicine, James H Quillen College of Medicine, East Tennessee State University; Chief of Pulmonary Medicine, Medical Director of Respiratory Therapy, Intensive Care Unit, Program Director of Pulmonary Diseases and Critical Care Medicine Fellowship, James H Quillen Veterans Affairs Medical Center
Contributor Information and Disclosures

Updated: Apr 2, 2009

Introduction

Background

Respiratory acidosis is a clinical disturbance due to alveolar hypoventilation. Production of carbon dioxide occurs rapidly, and failure of ventilation promptly increases the partial arterial pressure of carbon dioxide (PaCO2). The normal reference range for PaCO2 is 36-44 mm Hg. Alveolar hypoventilation leads to an increased PaCO2 (ie, hypercapnia). The increase in PaCO2, in turn, decreases the bicarbonate (HCO3 -)/PaCO2, decreasing the pH. Hypercapnia and respiratory acidosis ensue when impairment in ventilation occurs and the removal of carbon dioxide by the lungs is less than the production of carbon dioxide in the tissues.

Respiratory acidosis can be acute or chronic. In acute respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range (ie, >45 mm Hg) with an accompanying acidemia (ie, pH <7.35). In chronic respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range, with a normal or near-normal pH secondary to renal compensation and an elevated serum bicarbonate value (ie, >30 mm Hg).

Acute respiratory acidosis is present when an abrupt failure of ventilation occurs. This failure in ventilation may be caused by depression of the central respiratory center by cerebral disease or drugs, an inability to ventilate adequately owing to  a neuromuscular disease (eg, myasthenia gravisamyotrophic lateral sclerosisGuillain-Barré syndromemuscular dystrophy), or airway obstruction related to asthma or chronic obstructive pulmonary disease (COPD).

Chronic respiratory acidosis may be secondary to many disorders, including COPD. Hypoventilation in COPD involves multiple mechanisms, including decreased responsiveness to hypoxia and hypercapnia, increased ventilation-perfusion mismatch leading to increased dead space ventilation, and decreased diaphragmatic function due to fatigue and hyperinflation.

Chronic respiratory acidosis also may be secondary to obesity-hypoventilation syndrome (ie, pickwickian syndrome), neuromuscular disorders such as amyotrophic lateral sclerosis, and severe restrictive ventilatory defects as observed in interstitial fibrosis and thoracic deformities.

Lung diseases that primarily cause abnormalities in alveolar gas exchange usually do not cause hypoventilation; however, they tend to cause stimulation of ventilation and hypocapnia secondary to hypoxia. Hypercapnia only occurs if severe disease or respiratory muscle fatigue is present.

Pathophysiology

Metabolism rapidly generates a large quantity of volatile acid (carbon dioxide) and nonvolatile acid. The metabolism of fats and carbohydrates leads to the formation of a large amount of carbon dioxide. The carbon dioxide combines with water to form carbonic acid (H2 CO3). The lungs excrete the volatile fraction through ventilation, and acid accumulation does not occur. A significant alteration in ventilation that affects elimination of carbon dioxide can cause a respiratory acid-base disorder. The PaCO2 is normally maintained within the range of 35-45 mm Hg.1,2

Alveolar ventilation is under the control of the central respiratory centers, which are located in the pons and the medulla. Ventilation is influenced and regulated by chemoreceptors for PaCO2, PaO2, and pH located in the brainstem, as well as by neural impulses from lung-stretch receptors and impulses from the cerebral cortex. Failure of ventilation quickly increases the PaCO2.

In acute respiratory acidosis, the body's compensation occurs in 2 steps. The initial response is cellular buffering that occurs over minutes to hours. Cellular buffering elevates plasma bicarbonate values, but only slightly, approximately 1 mEq/L for each 10-mm Hg increase in PaCO2. The second step is renal compensation that occurs over 3-5 days. With renal compensation, renal excretion of carbonic acid is increased and bicarbonate reabsorption is increased.

The expected change in serum bicarbonate concentration in respiratory acidosis can be estimated as follows:

  • Acute respiratory acidosis: Bicarbonate increases 1 mEq/L for each 10-mm Hg rise in PaCO2.
  • Chronic respiratory acidosis: Bicarbonate increases 3.5 mEq/L for each 10-mm Hg rise in PaCO2.

The expected change in pH with respiratory acidosis can be estimated with the following equations:

  • Acute respiratory acidosis: Change in pH = 0.008 X (40 - PaCO2)
  • Chronic respiratory acidosis: Change in pH = 0.003 X (40 - PaCO2)

Respiratory acidosis does not have a great effect on electrolyte levels. Some small effects occur in calcium and potassium levels. Acidosis decreases binding of calcium to albumin and tends to increase serum ionized calcium levels. In addition, acidemia causes an extracellular shift of potassium, but respiratory acidosis rarely causes clinically significant hyperkalemia.

Mortality/Morbidity

The morbidity and mortality of respiratory acidosis depends on the underlying cause of the respiratory acidosis, associated conditions, the patient's compensatory mechanisms, and effectiveness of medical care.

Clinical

History

The clinical manifestations of respiratory acidosis often are those of the underlying disorder. Manifestations vary depending on the severity of the disorder and on the rate of development of hypercapnia. Mild-to-moderate hypercapnia that develops slowly usually has minimal symptoms.

Patients may be anxious and may complain of dyspnea. Some patients may have disturbed sleep and daytime hypersomnolence. As the PaCO2 increases, the anxiety may progress to delirium, and patients become progressively more confused, somnolent, and obtunded. This condition is sometimes referred to as carbon dioxide narcosis.

Physical

The findings upon physical examination in patients with respiratory acidosis usually are nonspecific and are related to the underlying illness or the cause of the respiratory acidosis.

  • Thoracic examination of patients with obstructive lung disease may demonstrate diffuse wheezing, hyperinflation (ie, barrel chest), decreased breath sounds, hyperresonance on percussion, and prolonged expiration. Rhonchi also may be heard.
  • Cyanosis may be noted if accompanying hypoxemia is present. Digital clubbing may indicate the presence of a chronic respiratory tract disease or other organ system disorders.
  • The patient's mental status may be depressed if he or she has severe elevations of PaCO2. Patients may have asterixis, myoclonus, and seizures.
  • Papilledema may be found during the retina examination. Conjunctival and superficial facial blood vessels also may be dilated.

Causes

Respiratory acidosis may occur due to a variety of etiologies, including the following:

  • Chronic obstructive pulmonary disease
    • Emphysema
    • Severe asthma3,4
    • Chronic bronchitis
  • Neuromuscular diseases
    • Amyotrophic lateral sclerosis
    • Diaphragm dysfunction and paralysis
    • Guillain-Barré syndrome
    • Myasthenia gravis
    • Muscular dystrophy
  • Chest wall disorders
    • Severe kyphoscoliosis
    • Status post thoracoplasty
    • Flail chest
    • Less commonly, ankylosing spondylitis, pectus excavatum,5 or pectus carinatum
  • Obesity-hypoventilation syndrome
  • Obstructive sleep apnea
  • CNS depression
    • Drugs - Narcotics, barbiturates, benzodiazepines, other CNS depressants
    • Neurologic disorders - Encephalitis, brainstem disease, trauma
    • Primary alveolar hypoventilation
  • Other lung and airway diseases - Laryngeal and tracheal stenosis

More on Respiratory Acidosis

Overview: Respiratory Acidosis
Differential Diagnoses & Workup: Respiratory Acidosis
Treatment & Medication: Respiratory Acidosis
Follow-up: Respiratory Acidosis
References

References

  1. Ehrsam RE, Heigenhauser GJ, Jones NL. Effect of respiratory acidosis on metabolism in exercise. J Appl Physiol. Jul 1982;53(1):63-9. [Medline].

  2. Kazmaier S, Weyland A, Buhre W, et al. Effects of respiratory alkalosis and acidosis on myocardial blood flow and metabolism in patients with coronary artery disease. Anesthesiology. Oct 1998;89(4):831-7. [Medline].

  3. Adnet F, Plaisance P, Borron SW, Levy A, Payen D. Prolonged severe hypercapnia complicating near fatal asthma in a 35-year-old woman. Intensive Care Med. Dec 1998;24(12):1335-8. [Medline].

  4. Cham GW, Tan WP, Earnest A, Soh CH. Clinical predictors of acute respiratory acidosis during exacerbation of asthma and chronic obstructive pulmonary disease. Eur J Emerg Med. Sep 2002;9(3):225-32. [Medline].

  5. Theerthakarai R, El-Halees W, Javadpoor S, Khan MA. Severe pectus excavatum associated with cor pulmonale and chronic respiratory acidosis in a young woman. Chest. Jun 2001;119(6):1957-61. [Medline].

  6. Wu JY, Kuo PH, Fan PC, Wu HD, Shih FY, Yang PC. The Role of Non-invasive Ventilation and Factors Predicting Extubation Outcome in Myasthenic Crisis. Neurocrit Care. 2009;10(1):35-42. [Medline].

  7. Zhang WB, Wang XY, Tian XY, Zhang H, Wang ZP, Gao YY. [Clinical value of noninvasive positive-pressure ventilation in chronic obstruction pulmonary disease combined with type II respiratory failure: a 4-year retrospective study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. Oct 2008;20(10):601-3. [Medline].

  8. Ali A, Flageole H. Diaphragmatic pacing for the treatment of congenital central alveolar hypoventilation syndrome. J Pediatr Surg. May 2008;43(5):792-6. [Medline].

  9. Duiverman ML, Wempe JB, Bladder G, et al. Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax. Dec 2008;63(12):1052-7. [Medline].

  10. Pollock JM, Deibler AR, Whitlow CT, et al. Hypercapnia-Induced Cerebral Hyperperfusion: An Underrecognized Clinical Entity. AJNR Am J Neuroradiol. Oct 14 2008;[Medline].

  11. Brimioulle S, Berre J, Dufaye P, Vincent JL, Degaute JP, Kahn RJ. Hydrochloric acid infusion for treatment of metabolic alkalosis associated with respiratory acidosis. Crit Care Med. Mar 1989;17(3):232-6. [Medline].

  12. Caruana-Montaldo B, Gleeson K, Zwillich CW. The control of breathing in clinical practice. Chest. Jan 2000;117(1):205-25. [Medline].

  13. Epstein SK, Singh N. Respiratory acidosis. Respir Care. Apr 2001;46(4):366-83. [Medline].

  14. Fall PJ. A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad Med. Mar 2000;107(3):249-50, 253-4, 257-8 passim. [Medline].

  15. Gluck SL. Acid-base. Lancet. Aug 8 1998;352(9126):474-9. [Medline].

  16. Hoo GW, Hakimian N, Santiago SM. Hypercapnic respiratory failure in COPD patients: response to therapy. Chest. Jan 2000;117(1):169-77. [Medline].

  17. Hooper RG, Browning M. Acid-base changes and ventilator mode during maintenance ventilation. Crit Care Med. Jan 1985;13(1):44-5. [Medline].

  18. Kassirer JP, Madias NE. Respiratory acid-base disorders. Hosp Pract. Dec 1980;15(12):57-9, 65-71. [Medline].

  19. Kellum JA. Determinants of plasma acid-base balance. Crit Care Clin. Apr 2005;21(2):329-46. [Medline].

  20. Kirsch DB, Jozefowicz RF. Neurologic complications of respiratory disease. Neurol Clin. Feb 2002;20(1):247-64, viii. [Medline].

  21. Krachman S, Criner GJ. Hypoventilation syndromes. Clin Chest Med. Mar 1998;19(1):139-55. [Medline].

  22. Martinez-Maldonado M, Sanchez-Montserrat R. Respiratory acidosis and alkalosis. Clin Nephrol. May 1977;7(5):191-200. [Medline].

  23. Murray J, Nadel J. Hypoventilation syndromes. In: Textbook of Respiratory Medicine. Vol 2. 4th ed. Philadelphia, Pa: WB Saunders; 2005:2075-80.

  24. Nowbar S, Burkart KM, Gonzales R. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. Jan 1 2004;116(1):1-7. [Medline].

  25. Plant PK, Owen JL, Elliott MW. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax. Jul 2000;55(7):550-4. [Medline].

  26. Schlichtig R, Grogono AW, Severinghaus JW. Current status of acid-base quantitation in physiology and medicine. Anesthesiol Clin North America. 1998;16 (1):211-233.

  27. Schlichtig R, Grogono AW, Severinghaus JW. Human PaCO2 and standard base excess compensation for acid-base imbalance. Crit Care Med. Jul 1998;26(7):1173-9. [Medline].

  28. Sterns RH. Fluid, electrolyte, and acid-base disturbances. J Amer Soc Nephrol. 2003;2(1):1-33.

  29. Wiseman AC, Linas S. Disorders of potassium and acid-base balance. Am J Kidney Dis. May 2005;45(5):941-9. [Medline].

Further Reading

Keywords

respiratory acidosis, hypoventilation, hypercapnia, alveolar hypoventilation, impaired ventilation, central respiratory depression, myasthenia gravis, amyotrophic lateral sclerosis, Guillain-Barre syndrome, muscular dystrophy, asthma, airway obstruction, chronic obstructive pulmonary disease, COPD, increased ventilation-perfusion mismatch, decreased diaphragm function, diaphragm dysfunction, obesity hypoventilation syndrome, obesity-hypoventilation syndrome, pickwickian syndrome, respiratory muscle fatigue, emphysema, chronic bronchitis, bronchitis, amyotrophic lateral sclerosis, diaphragm paralysis, kyphoscoliosis

Contributor Information and Disclosures

Author

Wael El Minaoui, MBBS, Fellow in Pulmonary/Critical Care Medicine, East Tennessee State University
Disclosure: Nothing to disclose.

Coauthor(s)

Ryland P Byrd Jr, MD, Professor, Department of Internal Medicine, Division of Pulmonary Medicine and Critical Care Medicine, James H Quillen College of Medicine, East Tennessee State University; Chief of Pulmonary Medicine, Medical Director of Respiratory Therapy, Intensive Care Unit, Program Director of Pulmonary Diseases and Critical Care Medicine Fellowship, James H Quillen Veterans Affairs Medical Center
Ryland P Byrd Jr, MD is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society, and Southern Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Oleh Wasyl Hnatiuk, MD, Program Director, National Capital Consortium, Pulmonary and Critical Care, Walter Reed Army Medical Center; Associate Professor, Department of Medicine, Uniformed Services University of Health Sciences
Oleh Wasyl Hnatiuk, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Gregg T Anders, DO, Medical Director, Great Plains Regional Medical Command , Brook Army Medical Center; Clinical Associate Professor, Department of Internal Medicine, Division of Pulmonary Disease, University of Texas Health Science Center at San Antonio
Gregg T Anders, DO is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society
Disclosure: Nothing to disclose.

CME Editor

Timothy D Rice, MD, Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Saint Louis University School of Medicine
Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians
Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA
Zab Mosenifar, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, and American Thoracic Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.